Loading stock data...

Panjon Ltd.

BSE: PANJON

BSE
18.88 -0.05 (-0.26%)

Prev Close

18.93

Open Price

18.93

Volume

5,055

Today Low / High

18.36 / 18.93

52 WK Low / High

16.75 / 32.75

Range

18 - 20

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 18.88, reflecting a change of -0.05 (-0.26413%). The expected target range on the BSE is 18 - 20. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

08 Oct 18.93 -0.26%
07 Oct 18.75 0.96%
06 Oct 19.35 -3.10%
03 Oct 19.50 -1.49%
01 Oct 18.25 5.26%
30 Sep 18.50 -2.76%
29 Sep 17.55 4.56%
26 Sep 18.85 -3.40%
25 Sep 18.54 -0.97%
24 Sep 18.88 -2.01%
23 Sep 18.54 -0.49%
22 Sep 19.50 -4.92%
19 Sep 19.10 -1.62%
18 Sep 19.98 -2.75%
17 Sep 19.06 0.26%
16 Sep 19.60 -2.76%
15 Sep 19.01 2.74%
12 Sep 19.70 -1.12%
11 Sep 19.14 0.37%
10 Sep 19.20 0.16%

Panjon Ltd. Graph

Panjon Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Panjon Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 18.88, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 18.88 19.07 17.16 - 20.98
19.26 15.41 - 23.11
19.45 13.61 - 25.28
Bearish Scenario 18.88 18.69 16.82 - 20.56
18.50 14.80 - 22.20
18.31 12.82 - 23.81

Overview of Panjon Ltd.

ISIN

INE744D01019

Industry

Medical - Pharmaceuticals

Vol.Avg

12,554

Market Cap

324,066,251

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

27.19

DCF

-9

Financial Ratios Every Investor Needs

Stock Rating Details for PANJON

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 1 Strong Sell
ROE Score 2 Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 30.46 Cr 25.98 Cr 4.48 Cr 0.1470 0.00 Cr 0.12 Cr 0.39 Cr 0.53 Cr 0.31 0.93 Cr 0.0173
2024-03-31 12.55 Cr 9.17 Cr 3.38 Cr 0.2691 0.00 Cr 0.13 Cr 1.76 Cr 0.15 Cr 0.10 0.41 Cr 0.0121
2023-03-31 6.09 Cr 2.08 Cr 4.01 Cr 0.6583 0.00 Cr 0.21 Cr 2.23 Cr 0.81 Cr 0.52 -0.01 Cr 0.1330
2022-03-31 8.43 Cr 4.49 Cr 3.94 Cr 0.4674 0.00 Cr 0.48 Cr 2.41 Cr -4.15 Cr -2.68 -4.05 Cr -0.4924
2021-03-31 14.54 Cr 11.76 Cr 2.78 Cr 0.1913 0.00 Cr 0.15 Cr 1.86 Cr 0.10 Cr 0.06 0.19 Cr 0.0066

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.44 Cr 20.05 Cr 3.51 Cr 16.5438 Cr 2.65 Cr 2.20 Cr 4.62 Cr 1.08 Cr 0.00 Cr 0.00 Cr 1.10 Cr 3.4302 Cr
2024-03-31 2.72 Cr 17.39 Cr 2.54 Cr 14.8529 Cr 1.44 Cr -1.28 Cr 3.74 Cr 0.89 Cr 0.00 Cr 0.00 Cr 1.05 Cr 2.3971 Cr
2023-03-31 1.47 Cr 14.90 Cr 1.42 Cr 13.4824 Cr 0.78 Cr -0.69 Cr 3.48 Cr 0.90 Cr 0.00 Cr 0.00 Cr 1.00 Cr 1.1609 Cr
2022-03-31 1.44 Cr 14.05 Cr 1.38 Cr 12.6629 Cr 0.81 Cr -0.63 Cr 3.77 Cr 0.94 Cr 0.00 Cr 0.00 Cr 1.07 Cr 1.0834 Cr
2021-03-31 0.31 Cr 19.25 Cr 2.44 Cr 16.8130 Cr 1.32 Cr 1.01 Cr 3.87 Cr 0.95 Cr 0.00 Cr 0.00 Cr 1.07 Cr 1.3663 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -4.3406 Cr -0.4368 Cr 2.5044 Cr -4.7652 Cr -2.2731 Cr 0.4446 Cr -0.4246 Cr 0.5274 Cr 1.2097 Cr 0.0000 Cr -0.8760 Cr
2024-03-31 -0.4223 Cr -0.2062 Cr 1.8753 Cr -0.6257 Cr 1.2469 Cr 2.7177 Cr -0.2034 Cr 0.1574 Cr 0.6562 Cr 0.0000 Cr 0.2608 Cr
2023-03-31 0.0407 Cr -0.1856 Cr 0.1805 Cr -0.1355 Cr 0.0357 Cr 1.4708 Cr -0.1762 Cr 0.1178 Cr 0.1712 Cr 0.0000 Cr 0.2914 Cr
2022-03-31 1.8224 Cr -0.1874 Cr -0.5116 Cr 1.6365 Cr 1.1233 Cr 1.4351 Cr -0.1858 Cr -4.0146 Cr -0.5132 Cr 0.0000 Cr 0.1020 Cr
2021-03-31 0.3368 Cr -0.0572 Cr -0.2438 Cr 0.2706 Cr 0.0358 Cr 0.3118 Cr -0.0662 Cr 0.1925 Cr -0.2392 Cr 0.0000 Cr -0.0671 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 6.42 Cr 4.33 Cr 2.09 Cr 0.3258 0.11 Cr 0.09 Cr 0.01 0.23 Cr 0.0148
2025-03-31 13.83 Cr 12.42 Cr 1.41 Cr 0.1019 0.24 Cr 0.23 Cr 0.13 0.36 Cr 0.0164
2024-12-31 11.16 Cr 9.67 Cr 1.49 Cr 0.1332 0.17 Cr 0.20 Cr 0.12 0.31 Cr 0.0179
2024-09-30 3.38 Cr 2.55 Cr 0.83 Cr 0.2454 -0.42 Cr 0.07 Cr 0.04 0.15 Cr 0.0197
2024-06-30 2.09 Cr 1.34 Cr 0.75 Cr 0.3595 -0.04 Cr 0.03 Cr 0.02 0.11 Cr 0.0165

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 0.44 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -16.54 Cr
2025-03-31 0.44 Cr 0.38 Cr 0.82 Cr 7.23 Cr 4.62 Cr 12.67 Cr 1.08 Cr 20.05 Cr 3.51 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.97 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -14.52 Cr
2024-09-30 1.97 Cr 0.03 Cr 2.01 Cr 2.40 Cr 4.32 Cr 12.80 Cr 0.79 Cr 17.95 Cr 3.43 Cr
2024-06-30 -2.72 Cr 5.44 Cr 2.72 Cr 0.00 Cr 0.00 Cr 2.72 Cr 0.00 Cr 0.00 Cr -14.85 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.10 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.20 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹763.10 ₹91,376,415,181.00 ₹234,880.00

Key Executives

Executive Director
Ms. Anju Jay Kothari

Gender: female

Year Born: 1966

Company Secretary & Compliance Officer
Ms. Arpita Vijay Vargiya

Gender: female

Year Born:

MD & Executive Chairman
Mr. Jay Kumar Kothari

Gender: male

Year Born: 1964

Chief Financial Officer
Mr. Pramod Kumar Ajmera

Gender: male

Year Born:

FAQs about Panjon Ltd.

Who is the CEO of the company?

The CEO is Jay Kumar Kothari.

What is the current market price of the stock?

The current price is ₹18.88.

What is the 52-week price range?

The range is ₹16.75-32.75.

What is the market capitalization of the company?

The market capitalization is ₹32.41 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 55.14.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Panjon Ltd. (ISIN: INE744D01019) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹32.41 crores and an average daily volume of 12,554 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.